Trial intelligence / Profile preview

Dose-response of continuous norepinephrine infusion to prevent post-spinal hypotension in obese parturients undergoing cesarean section

ChiCTR2200062650Phase 4Recruiting

Sponsor
Jiaxing Maternity and Child Health Care Hospital
Start
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of norepinephrine in intraoperative hypotension (IOH) (4 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoint: blood pressure. Started May 2022; status: recruiting.

02

Drugs

norepinephrine
03

Conditions

intraoperative hypotension (IOH)

Beyond the preview

Go deeper on ChiCTR2200062650.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200062650.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call